Coca-Cola HBC 1Q Net Sales Revenue Rose Beating Consensus
By Anthony O. Goriainoff
Coca-Cola HBC AG said Wednesday that first-quarter net sales revenue rose, beating consensus, and that it had greater confidence in achieving positive organic EBIT growth in 2023.
The bottler for Coca-Cola Co.--listed in both London and Athens--generated net sales revenue of 2.20 billion euros ($2.42 billion) compared with EUR1.77 billion for the first quarter of 2022.
Net sales revenue consensus was EUR2.05 billion, taken from Vuma and based on 18 analysts' estimates.
This was as volumes rose 2.6% to 621.1 million unit cases, and revenue per unit case was 21.3% higher at EUR3.55. A unit case contains 5.68 liters, or 24 servings.
The company said sparkling volumes grew by 2.9%, excluding Russia and Ukraine, and were driven by Trademark Coke up mid-single digits with overall sparkling volumes falling 1.6%. Energy volumes rose 23.8%, excluding Russia and Ukraine, with overall energy volumes up 11.9%. Excluding Russia and Ukraine coffee grew 25%, with good performance across all segments. Still volumes fell 13.3% as growth in sports drinks was offset by declines elsewhere, notably in water, the company said.
Write to Anthony O. Goriainoff at anthony.orunagoriainoff@dowjones.com
(END) Dow Jones Newswires
May 03, 2023 02:59 ET (06:59 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
For Bond Investors, Delayed Rate Cuts Demand a Different Playbook
-
What’s Happening In the Markets This Week
-
How the Tokyo Stock Exchange Is Pushing for Better Shareholder Returns
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Where We See Opportunities After an Ugly Month for Stocks
-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
When Will the Fed Start Cutting Interest Rates?
-
What’s the Difference Between the CPI and PCE Indexes?
-
Berkshire Hathaway Earnings: Strong Insurance Results Continue to Lift Revenue and Profitability
-
10 Questions for Berkshire Hathaway’s 2024 Annual Meeting
-
After Earnings, Is Ford Stock a Buy, a Sell, or Fairly Valued?
-
3 Dividend Stocks for May 2024
-
Amgen Earnings: Obesity Drug Update Is Highly Encouraging
-
What’s Going on With Apple, Tesla, and Alphabet?
-
Apple Earnings: A Weak 2024, but Optimism for 2025
-
4 Utility Stocks to Play the AI Data Center Boom